Explore the Agenda

8:00 am Registration & Morning Coffee

8:30 am Chairs Opening Remarks

Former Senior Vice President, People Strategy & Administrative Operations, Senti Biosciences Inc.

Scaling People Strategy to Match Commercial Ambition

8:40 am Panel: The Talent Inflection Point: What HR & TA Leaders Must Get Right During Commercialization & Ownership Transition

Chief People Officer, Cardurion Pharmaceuticals
Vice President, Talent Acquisition, Intellia Therapeutics
Chief Relationship Officer & Platinum Executive Coach, Lead3R

For life sciences organizations, the moments of greatest strategic change, a commercial launch, an IPO, or a move to private ownership, are also the moments of greatest people risk. Culture can fracture, critical talent can walk, and the hiring demands can overwhelm even the best-prepared teams. This panel draws on real experience of navigating these inflection points to surface the people decisions that matter most, the mistakes most commonly made, and the practical approaches that keep organizations on track through their most consequential transitions.

9:20 am Discover: Re-Energizing Engagement by Bringing Performance & Reward Back to Basics in a Modern Biotech

Head of People, Grey Wolf Therapeutics
  • How can biotechs cut through complexity to strengthen engagement, motivation, and trust, especially after years of industry volatility and inconsistent talent practices?
  • Learn how Grey Wolf Therapeutics implemented a back-to-basics, radically transparent approach to objective-setting, performance clarity, and pay communication, anchored on one simple principle: every employee should confidently answer “What do you want me to do?”, “What does good look like?”, and “What will I be rewarded with if I achieve it?”
  • Discover how this restored HR credibility, eliminated ambiguity, reduced pockets of pay disparity, and unlocked significant cultural energy, enabling higher engagement, greater fairness, and a more empowered, high-performing workforce without expensive L&D programs or large HR teams

9:40 am Develop: Simplifying Complexity While Scaling Sustainably

Head of People, Grey Wolf Therapeutics

This interactive Q&A explores how life sciences organizations can scale operations, capability, and workforce complexity without losing clarity, engagement, and organizational discipline no matter what their size. Drawing on the case studies, this session focuses on how to balance growth with simplicity.

10:00 am Action: Building Simplicity & Scalability Into Your Operating Model

Building on the Q&A, this roundtable creates a practical space to reflect on how complexity is showing up in your own organization, and to identify the highest-impact moves to simplify and scale effectively whether you are emerging or established.

Leave with practical actions to reduce complexity, strengthen clarity, and build a more scalable and effective life sciences organization.

10:20 am Networking Break & Refreshments

Track A - Human Resources

Clearing the Path for Faster, Smarter Decisions & Navigating Generational Complexity

10:50 am Discover: Stopping Organizational Swirl by Clarifying Decision‑Making in R&D

Senior Vice President, Development Operations, Ultragenyx Pharmaceutical Inc.
  • How can life sciences organizations reduce decision‑making friction and role confusion that slows execution across R&D?
  • Learn how Ultragenyx diagnosed ‘organizational swirl’ and introduced the Stop the Swirl initiative and Fix It framework using live forums, real‑time coaching, and embedded decision tools
  • See how this approach drove sustained cross‑level engagement over 18 months, with measurable participation data and strong qualitative feedback, leading to clearer accountability, shared decision language, and improved execution discipline across teams

11:10 am Discover: Where Organizations Unknowingly Build People & Operating Debt, & How HR Can Intervene Earlier to Prevent It

Senior Vice President, Head of People, 5am Ventures
  • Understand what people and operating debt actually looks like in practice, the hidden costs of misaligned roles, unclear accountability, and talent decisions that compound over time
  • Explore the early intervention points where HR can diagnose and address structural debt before it becomes a strategic liability, and the frameworks that make earlier action possible
  • Learn how embedding role clarity, decision rights, and accountability structures earlier in the organization's lifecycle delivers measurable improvements in
  • Execution speed, talent retention, and commercial performance

11:30 am Develop: Clearing Friction & Building Clarity: Decision-Making, Conduct, & the Generational Dimension

Senior Vice President, Development Operations, Ultragenyx Pharmaceutical Inc.
Senior Vice President, Head of People, 5am Ventures

This interactive Q&A explores two distinct but connected challenges: the structural friction created by unclear decision-making in complex organizations, and the cultural friction created by generational divides in conduct and expectations.

Both slow execution and eroded trust demand active HR intervention. Participants will examine what these challenges have in common, and where they require fundamentally different approaches.

  • How do you diagnose whether your organization’s execution problems are structural (unclear decisions) or cultural (misaligned expectations)?
  • What tools or frameworks best help teams develop shared decision language across organizational levels?
  • How do you build a conduct framework that is clear and consistent while genuinely accounting for generational difference?
  • Where do decision-making clarity and generational culture challenges most often intersect, and how do you address both at once?

11:50 am Action: Rebuilding Clarity: From Swirl to Accountability, From Generation Gap to Shared Standards

Building on the Q&A, this roundtable invites participants to examine the decision-making and cultural clarity challenges that are costing their own organizations the most, and to develop practical, peer tested approaches to addressing them.

The conversation will draw on both the structural and human dimensions of organizational clarity explored in the Discover sessions.

  • Where is decision-making friction causing the most damage to execution in your organization right now?
  • What is the most effective intervention you have seen for building shared decision-language across levels or functions?
  • How are you approaching generational differences in conduct expectations, as a training challenge, a culture challenge, or a structural one?
  • What would clearer accountability and shared standards look like in your organization, and what is standing in the way?

Leave with practical frameworks for reducing organizational friction and building the clarity your teams need to execute with greater speed and confidence

Track B - Talent Acquisition
Track C - Learning & Development

12:10 pm Networking Lunch

1:10 pm Speed Learning

Global Head of Culture & People Experience, Legend Biotech
Global Head of Talent Management & R&D, Novartis AG
Head of Talent Strategy & Enablement, Charles River Laboratories
Global Human Resources Head for R&D & Enabling Functions,, CSL
Head, Global Talent Acquisition, Blueprint Medicines
Vice President, Human Resources, Arcus Biosciences
Senior Vice President, Head of People, 5am Ventures
Vice President, Talent Management, Ardelyx
Senior Vice President, Development Operations, Ultragenyx Pharmaceutical Inc.

End the conference with a high-energy Speed Learning session designed to maximize the value of your time in the room. Through a series of rapid-fire, facilitated discussions, you’ll tackle a curated set of the most pressing challenges facing HR, TA, and L&D leaders today – gaining diverse perspectives, sharing practical solutions, and leaving with a final set of actionable ideas to take back to your organization.

2:10 pm Chair’s Closing Remarks & End of LEAP HR: Life Sciences East 2026